Skip to main content
Equibles

Legal & General Group Plc

Position in TBPH — Theravance Biopharma, Inc.

CIK 764068 London, X0
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$589,118
+$152,078 QoQ
Shares Held
34,654
+28.7% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. TBPH ranks #126 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in TBPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $589,118 34,654
2026-03-31 $437,040 26,928
2025-12-31 $73,754 3,942
2025-09-30 $56,399 3,863
2025-06-30 $45,664 4,140
2025-03-31 $29,754 3,332
2024-12-31 $387,860 41,218
2024-09-30 $435,842 54,075
2024-06-30 $458,555 54,075
2024-03-31 $470,197 52,419
2023-12-31 $566,427 50,394
2023-09-30 $477,937 55,381
2023-06-30 $591,978 57,196
2023-03-31 $616,224 56,795
2022-12-31 $621,486 55,391
2022-09-30 $566,409 55,859
2022-06-30 $533,670 58,904
2022-03-31 $548,629 57,388
2021-12-31 $634,235 57,397
2021-09-30 $316,341 42,749
2021-06-30 $457,742 31,525
2021-03-31 $634,015 31,064
2020-12-31 $555,578 31,265
2020-09-30 $462,252 31,265
2020-06-30 $703,059 33,495
2020-03-31 $785,462 33,988